News & Updates

Show Multimedia Only

No benefit from adding interferon beta-1a to remdesivir in COVID-19

16 Dec 2021 by

Adding interferon beta-1a to remdesivir did not hasten time to recovery among adults hospitalized with COVID-19, according to results of the phase III ACTT*-3 trial.

16 Dec 2021

Certain IBD meds tied to excess risk of COVID-19 hospitalization

16 Dec 2021 by

While there are no differences in COVID-19-related outcomes in patients with inflammatory bowel disease (IBD) between those in remission vs those who are not, being on medications such as corticosteroids and aminosalicylates may put them at higher risk of hospitalization, suggest studies presented at AIBD 2021.

16 Dec 2021

Diabetes not a risk factor for long COVID

16 Dec 2021 by

Diabetes does not appear to predispose SARS-CoV-2–infected patients to long-term post-COVID-19 symptoms, a study reports.

16 Dec 2021

Immune memory persistent but exhausted 1 year after COVID-19

16 Dec 2021 by

In convalescent patients with the coronavirus disease 2019 (COVID-19), humoral and cellular responses against the SARS-CoV-2 virus remain robust at 1 year after infection, according to a recent study. However, a notable dysfunction in CD4+ T cells emphasizes the need for vaccination to prevent reinfection.

16 Dec 2021

Entecavir prevents HBV reactivation in individuals on DAA for HCV/HBV dual infection

15 Dec 2021

For patients undergoing direct acting antiviral (DAA) therapy for hepatitis C virus (HCV)/hepatitis B virus (HBV) dual infection, cotreatment with entecavir helps avert reactivation of HBV, as shown in a study.

15 Dec 2021

Is prior allergy a deal-breaker for COVID-19 vacc?

13 Dec 2021 by

A large prospective, observational study has suggested that while individuals with a history of high-risk allergy may have an increased risk of allergic reactions following receipt of a messenger RNA (mRNA) COVID-19 vaccine, they are still able to receive both vaccine doses.

13 Dec 2021

Saliva outperforms nasopharyngeal swabs for COVID-19 detection

13 Dec 2021

Compared with nasopharyngeal swabs (NPS), saliva samples provide higher diagnostic yield for detecting positivity to the coronavirus disease 2019 (COVID-19), a recent study has found.

13 Dec 2021

Simple, at-home test helps screen COVID-19-related anosmia, ageusia

09 Dec 2021 by

A quick, objective testing kit for daily self-assessment of olfactory and gustatory function can effectively measure smell and taste losses associated with COVID-19, as shown in a study.

09 Dec 2021